Dihydrofolate reductase catalyzes the conversion of which compound to what?

Study for the ASAP VI Oncology Exam. Utilize flashcards and multiple-choice questions with hints and explanations. Prepare thoroughly for your oncology certification test!

Dihydrofolate reductase is an important enzyme in the folate metabolism pathway, and its primary role is to catalyze the reduction of dihydrofolate to tetrahydrofolate. Tetrahydrofolate is an essential coenzyme involved in the synthesis of purines and the amino acid methionine, as well as in the conversion of deoxyuridine monophosphate (dUMP) to thymidine monophosphate (TMP). The conversion from dihydrofolate to tetrahydrofolate is crucial for maintaining an adequate supply of tetrahydrofolate, which is vital for nucleotide synthesis and cell division.

The other options do not reflect the correct activity of dihydrofolate reductase. Tetrahydrofolate is not converted back to dihydrofolate by this enzyme; rather, it is produced from dihydrofolate. The conversion of dUMP to TMP is handled by thymidylate synthase, not dihydrofolate reductase. Lastly, the conversion of 5-fluorouracil to capecitabine involves different enzymatic processes relevant to drug metabolism and is unrelated to the action of dihydrofolate reductase

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy